Loading…

Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries

A randomized controlled trial (RCT) study is being conducted in Uganda to determine the safety and immunogenicity of fractional doses of the 17DD yellow fever vaccine in children aged 9 to 23 months. Adverse event(s) following immunization (AEFI) are being monitored through a novel approach for clin...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2022-03, Vol.116, p.S116-S117
Main Authors: Sciarratta, C., Sserunga, M. Najjengo, Sekiziyivu, A.B., Lubega, I., Nakato, W. Nansozi, Twinomuhwezi, E., Tumwine, C., Wasswa, C. Kaliisa, Doshi, R., Chu, S., Gidudu, J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S117
container_issue
container_start_page S116
container_title International journal of infectious diseases
container_volume 116
creator Sciarratta, C.
Sserunga, M. Najjengo
Sekiziyivu, A.B.
Lubega, I.
Nakato, W. Nansozi
Twinomuhwezi, E.
Tumwine, C.
Wasswa, C. Kaliisa
Doshi, R.
Chu, S.
Gidudu, J.
description A randomized controlled trial (RCT) study is being conducted in Uganda to determine the safety and immunogenicity of fractional doses of the 17DD yellow fever vaccine in children aged 9 to 23 months. Adverse event(s) following immunization (AEFI) are being monitored through a novel approach for clinical vaccine trial settings in low- and middle-income countries: diary cards completed by participants’ parents during the first 14 days post-vaccination, when 95% of AEFI occur. The cards instruct parents how to use a digital thermometer and record prespecified conditions daily including fever. We assessed parent acceptability of the card along with its ability to obtain comprehensive AEFI data. We conducted qualitative surveys of a convenience sample of parents who completed an AEFI diary card per participant during their 14-day follow-up visits at 3 sites [2 urban, 1 rural]. Completed diary cards on file were systematically sampled (every 3rd) per site and reviewed for completeness of conditions including morning and evening temperatures, fever, seizure, diarrhea, persistent crying, rash, swelling at injection site, vomiting, and ‘other specify’. SAS Statistical Software was used to analyze quantitative data and qualitative data was analyzed using thematic analyses in MS Excel. Among 75 parents interviewed, 58 (77.3%) were ‘very confident’ in their understanding of the conditions listed and 69 (92.0%) reported it was ‘easy to understand’. Overall, 78.6% (n=59) of parents reported the card taught them how to use a digital thermometer to monitor their child's body temperature and how to track the child's health after vaccination. We reviewed 147 diary cards; 135 (91.8%) cards had >80% of all conditions completed and 130 (88.4%) cards had >80% of temperatures recorded twice daily. Our results show majority of parents that used a diary card for AEFI monitoring found it to be easy to use and understand. Most diary cards were completed for all prespecified conditions during the 14-day follow-up period. These results support the use of diary cards to monitor vaccine safety in Uganda and further exploration of the role of diary cards in AEFI monitoring during clinical trials in low- to middle-income countries.
doi_str_mv 10.1016/j.ijid.2021.12.275
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_dc77822d8f144a8bb84bc626947bf283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S120197122101167X</els_id><doaj_id>oai_doaj_org_article_dc77822d8f144a8bb84bc626947bf283</doaj_id><sourcerecordid>S120197122101167X</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2065-ec4379b65208ce36560a7679e54ed66f95f694e0294ff8a57091665752dcdc1a3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxiMEEqXwApx8hENS24n_RHCptg1daREcdpF6shx7vHKU2sjOtuqz8XI4LOLIydbM9_00M19VvSe4IZjwq6nxk7cNxZQ0hDZUsBfVBZFC1i0j5GX5U0zqXhD6unqT84Qx7jiXF9WvQ_bhiHRA17fDFn3XCcKCbrxOz2ijk0VDnOf4tGqGpM3iY9BzfRMzoHtYO2iAR0jog7sfPqIf2hgf9KpCPqDDUQerPyGN9jHOyMWENjFkbyGdNWtlOC2nBGgz--CNntE-eT3n1b6LT3WZzKKv3toZ6m0w8aEo4yksyUN-W71yRQrv_r6X1WG43W_u6t23L9vN9a42FHNWg-la0Y-cUSwNtJxxrAUXPbAOLOeuZ473HWDad85JzQTuCedMMGqNNUS3l9X2zLVRT-pn8g_lOipqr_4UYjoqnRZvZlDWCCEptdKRrtNyHGU3Gk4LX4yOyraw6JllUsw5gfvHI1itUapJrVGqNUpFqCpRFtPnswnKlo8eksrGQzBgfQKzlDH8_-y_AT4Hp3w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries</title><source>ScienceDirect</source><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Sciarratta, C. ; Sserunga, M. Najjengo ; Sekiziyivu, A.B. ; Lubega, I. ; Nakato, W. Nansozi ; Twinomuhwezi, E. ; Tumwine, C. ; Wasswa, C. Kaliisa ; Doshi, R. ; Chu, S. ; Gidudu, J.</creator><creatorcontrib>Sciarratta, C. ; Sserunga, M. Najjengo ; Sekiziyivu, A.B. ; Lubega, I. ; Nakato, W. Nansozi ; Twinomuhwezi, E. ; Tumwine, C. ; Wasswa, C. Kaliisa ; Doshi, R. ; Chu, S. ; Gidudu, J.</creatorcontrib><description>A randomized controlled trial (RCT) study is being conducted in Uganda to determine the safety and immunogenicity of fractional doses of the 17DD yellow fever vaccine in children aged 9 to 23 months. Adverse event(s) following immunization (AEFI) are being monitored through a novel approach for clinical vaccine trial settings in low- and middle-income countries: diary cards completed by participants’ parents during the first 14 days post-vaccination, when 95% of AEFI occur. The cards instruct parents how to use a digital thermometer and record prespecified conditions daily including fever. We assessed parent acceptability of the card along with its ability to obtain comprehensive AEFI data. We conducted qualitative surveys of a convenience sample of parents who completed an AEFI diary card per participant during their 14-day follow-up visits at 3 sites [2 urban, 1 rural]. Completed diary cards on file were systematically sampled (every 3rd) per site and reviewed for completeness of conditions including morning and evening temperatures, fever, seizure, diarrhea, persistent crying, rash, swelling at injection site, vomiting, and ‘other specify’. SAS Statistical Software was used to analyze quantitative data and qualitative data was analyzed using thematic analyses in MS Excel. Among 75 parents interviewed, 58 (77.3%) were ‘very confident’ in their understanding of the conditions listed and 69 (92.0%) reported it was ‘easy to understand’. Overall, 78.6% (n=59) of parents reported the card taught them how to use a digital thermometer to monitor their child's body temperature and how to track the child's health after vaccination. We reviewed 147 diary cards; 135 (91.8%) cards had &gt;80% of all conditions completed and 130 (88.4%) cards had &gt;80% of temperatures recorded twice daily. Our results show majority of parents that used a diary card for AEFI monitoring found it to be easy to use and understand. Most diary cards were completed for all prespecified conditions during the 14-day follow-up period. These results support the use of diary cards to monitor vaccine safety in Uganda and further exploration of the role of diary cards in AEFI monitoring during clinical trials in low- to middle-income countries.</description><identifier>ISSN: 1201-9712</identifier><identifier>EISSN: 1878-3511</identifier><identifier>DOI: 10.1016/j.ijid.2021.12.275</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>International journal of infectious diseases, 2022-03, Vol.116, p.S116-S117</ispartof><rights>2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S120197122101167X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3535,27903,27904,45759</link.rule.ids></links><search><creatorcontrib>Sciarratta, C.</creatorcontrib><creatorcontrib>Sserunga, M. Najjengo</creatorcontrib><creatorcontrib>Sekiziyivu, A.B.</creatorcontrib><creatorcontrib>Lubega, I.</creatorcontrib><creatorcontrib>Nakato, W. Nansozi</creatorcontrib><creatorcontrib>Twinomuhwezi, E.</creatorcontrib><creatorcontrib>Tumwine, C.</creatorcontrib><creatorcontrib>Wasswa, C. Kaliisa</creatorcontrib><creatorcontrib>Doshi, R.</creatorcontrib><creatorcontrib>Chu, S.</creatorcontrib><creatorcontrib>Gidudu, J.</creatorcontrib><title>Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries</title><title>International journal of infectious diseases</title><description>A randomized controlled trial (RCT) study is being conducted in Uganda to determine the safety and immunogenicity of fractional doses of the 17DD yellow fever vaccine in children aged 9 to 23 months. Adverse event(s) following immunization (AEFI) are being monitored through a novel approach for clinical vaccine trial settings in low- and middle-income countries: diary cards completed by participants’ parents during the first 14 days post-vaccination, when 95% of AEFI occur. The cards instruct parents how to use a digital thermometer and record prespecified conditions daily including fever. We assessed parent acceptability of the card along with its ability to obtain comprehensive AEFI data. We conducted qualitative surveys of a convenience sample of parents who completed an AEFI diary card per participant during their 14-day follow-up visits at 3 sites [2 urban, 1 rural]. Completed diary cards on file were systematically sampled (every 3rd) per site and reviewed for completeness of conditions including morning and evening temperatures, fever, seizure, diarrhea, persistent crying, rash, swelling at injection site, vomiting, and ‘other specify’. SAS Statistical Software was used to analyze quantitative data and qualitative data was analyzed using thematic analyses in MS Excel. Among 75 parents interviewed, 58 (77.3%) were ‘very confident’ in their understanding of the conditions listed and 69 (92.0%) reported it was ‘easy to understand’. Overall, 78.6% (n=59) of parents reported the card taught them how to use a digital thermometer to monitor their child's body temperature and how to track the child's health after vaccination. We reviewed 147 diary cards; 135 (91.8%) cards had &gt;80% of all conditions completed and 130 (88.4%) cards had &gt;80% of temperatures recorded twice daily. Our results show majority of parents that used a diary card for AEFI monitoring found it to be easy to use and understand. Most diary cards were completed for all prespecified conditions during the 14-day follow-up period. These results support the use of diary cards to monitor vaccine safety in Uganda and further exploration of the role of diary cards in AEFI monitoring during clinical trials in low- to middle-income countries.</description><issn>1201-9712</issn><issn>1878-3511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kc9u1DAQxiMEEqXwApx8hENS24n_RHCptg1daREcdpF6shx7vHKU2sjOtuqz8XI4LOLIydbM9_00M19VvSe4IZjwq6nxk7cNxZQ0hDZUsBfVBZFC1i0j5GX5U0zqXhD6unqT84Qx7jiXF9WvQ_bhiHRA17fDFn3XCcKCbrxOz2ijk0VDnOf4tGqGpM3iY9BzfRMzoHtYO2iAR0jog7sfPqIf2hgf9KpCPqDDUQerPyGN9jHOyMWENjFkbyGdNWtlOC2nBGgz--CNntE-eT3n1b6LT3WZzKKv3toZ6m0w8aEo4yksyUN-W71yRQrv_r6X1WG43W_u6t23L9vN9a42FHNWg-la0Y-cUSwNtJxxrAUXPbAOLOeuZ473HWDad85JzQTuCedMMGqNNUS3l9X2zLVRT-pn8g_lOipqr_4UYjoqnRZvZlDWCCEptdKRrtNyHGU3Gk4LX4yOyraw6JllUsw5gfvHI1itUapJrVGqNUpFqCpRFtPnswnKlo8eksrGQzBgfQKzlDH8_-y_AT4Hp3w</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Sciarratta, C.</creator><creator>Sserunga, M. Najjengo</creator><creator>Sekiziyivu, A.B.</creator><creator>Lubega, I.</creator><creator>Nakato, W. Nansozi</creator><creator>Twinomuhwezi, E.</creator><creator>Tumwine, C.</creator><creator>Wasswa, C. Kaliisa</creator><creator>Doshi, R.</creator><creator>Chu, S.</creator><creator>Gidudu, J.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202203</creationdate><title>Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries</title><author>Sciarratta, C. ; Sserunga, M. Najjengo ; Sekiziyivu, A.B. ; Lubega, I. ; Nakato, W. Nansozi ; Twinomuhwezi, E. ; Tumwine, C. ; Wasswa, C. Kaliisa ; Doshi, R. ; Chu, S. ; Gidudu, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2065-ec4379b65208ce36560a7679e54ed66f95f694e0294ff8a57091665752dcdc1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sciarratta, C.</creatorcontrib><creatorcontrib>Sserunga, M. Najjengo</creatorcontrib><creatorcontrib>Sekiziyivu, A.B.</creatorcontrib><creatorcontrib>Lubega, I.</creatorcontrib><creatorcontrib>Nakato, W. Nansozi</creatorcontrib><creatorcontrib>Twinomuhwezi, E.</creatorcontrib><creatorcontrib>Tumwine, C.</creatorcontrib><creatorcontrib>Wasswa, C. Kaliisa</creatorcontrib><creatorcontrib>Doshi, R.</creatorcontrib><creatorcontrib>Chu, S.</creatorcontrib><creatorcontrib>Gidudu, J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sciarratta, C.</au><au>Sserunga, M. Najjengo</au><au>Sekiziyivu, A.B.</au><au>Lubega, I.</au><au>Nakato, W. Nansozi</au><au>Twinomuhwezi, E.</au><au>Tumwine, C.</au><au>Wasswa, C. Kaliisa</au><au>Doshi, R.</au><au>Chu, S.</au><au>Gidudu, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries</atitle><jtitle>International journal of infectious diseases</jtitle><date>2022-03</date><risdate>2022</risdate><volume>116</volume><spage>S116</spage><epage>S117</epage><pages>S116-S117</pages><issn>1201-9712</issn><eissn>1878-3511</eissn><abstract>A randomized controlled trial (RCT) study is being conducted in Uganda to determine the safety and immunogenicity of fractional doses of the 17DD yellow fever vaccine in children aged 9 to 23 months. Adverse event(s) following immunization (AEFI) are being monitored through a novel approach for clinical vaccine trial settings in low- and middle-income countries: diary cards completed by participants’ parents during the first 14 days post-vaccination, when 95% of AEFI occur. The cards instruct parents how to use a digital thermometer and record prespecified conditions daily including fever. We assessed parent acceptability of the card along with its ability to obtain comprehensive AEFI data. We conducted qualitative surveys of a convenience sample of parents who completed an AEFI diary card per participant during their 14-day follow-up visits at 3 sites [2 urban, 1 rural]. Completed diary cards on file were systematically sampled (every 3rd) per site and reviewed for completeness of conditions including morning and evening temperatures, fever, seizure, diarrhea, persistent crying, rash, swelling at injection site, vomiting, and ‘other specify’. SAS Statistical Software was used to analyze quantitative data and qualitative data was analyzed using thematic analyses in MS Excel. Among 75 parents interviewed, 58 (77.3%) were ‘very confident’ in their understanding of the conditions listed and 69 (92.0%) reported it was ‘easy to understand’. Overall, 78.6% (n=59) of parents reported the card taught them how to use a digital thermometer to monitor their child's body temperature and how to track the child's health after vaccination. We reviewed 147 diary cards; 135 (91.8%) cards had &gt;80% of all conditions completed and 130 (88.4%) cards had &gt;80% of temperatures recorded twice daily. Our results show majority of parents that used a diary card for AEFI monitoring found it to be easy to use and understand. Most diary cards were completed for all prespecified conditions during the 14-day follow-up period. These results support the use of diary cards to monitor vaccine safety in Uganda and further exploration of the role of diary cards in AEFI monitoring during clinical trials in low- to middle-income countries.</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.ijid.2021.12.275</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1201-9712
ispartof International journal of infectious diseases, 2022-03, Vol.116, p.S116-S117
issn 1201-9712
1878-3511
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_dc77822d8f144a8bb84bc626947bf283
source ScienceDirect; BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
title Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T12%3A19%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20an%20AEFI%20Parent%20Diary%20Card%20Following%20Fractional-Dose%20Yellow%20Fever%20(fYF)%20Vaccination%20in%20Uganda;%20a%20Tool%20for%20Consideration%20for%20Future%20Clinical%20Trials%20in%20Low-%20and%20Middle-Income%20Countries&rft.jtitle=International%20journal%20of%20infectious%20diseases&rft.au=Sciarratta,%20C.&rft.date=2022-03&rft.volume=116&rft.spage=S116&rft.epage=S117&rft.pages=S116-S117&rft.issn=1201-9712&rft.eissn=1878-3511&rft_id=info:doi/10.1016/j.ijid.2021.12.275&rft_dat=%3Celsevier_doaj_%3ES120197122101167X%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2065-ec4379b65208ce36560a7679e54ed66f95f694e0294ff8a57091665752dcdc1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true